Improved Proliferation and Differentiation Capacity of Human Mesenchymal Stromal Cells Cultured with Basement-membrane Extracellular Matrix Proteins
Overview
Pharmacology
Authors
Affiliations
Background Aims: In vitro cultured mesenchymal stromal cells (MSC) are characterized by a short proliferative lifespan, an increasing loss of proliferation capacity and progressive reduction of differentiation potential. Laminin-1, laminin-5, collagen IV and fibronectin are important constituents of the basement membrane extracellular matrix (ECM) that are involved in a variety of cellular activities, including cell attachment and motility.
Methods And Results: The in vitro proliferation capacity of MSC was significantly improved when the cells were incubated in the presence of basement membrane ECM proteins. For example, a mixture of proteins improved proliferation capacity 250-fold in comparison with standard conditions after five passages. Furthermore, in colony-forming unit-fibroblast (CFU-F) assays colony numbers and size were significantly extended. Blocking specific integrin cell-surface receptors, positive effects on the proliferation capacity of MSC were inhibited. Additionally, when MSC were co-cultivated with ECM proteins, cells maintained their multipotential differentiation capacity throughout many culture passages in comparison with cells cultivated on plastic. However, expansion of MSC on laminin-5 suppressed any subsequent chondrogenic differentiation.
Conclusions: Our results suggest that expansion of bone marrow-derived MSC in the presence of ECM proteins is a powerful approach for generating large numbers of MSC, showing a prolonged capacity to differentiate into mesodermal cell lineages, with the exception of the lack of chondrogenesis by using laminin-5 coating.
Managing the Heterogeneity of Mesenchymal Stem Cells for Cartilage Regenerative Therapy: A Review.
Goh D, Yang Y, Lee E, Hui J, Yang Z Bioengineering (Basel). 2023; 10(3).
PMID: 36978745 PMC: 10045936. DOI: 10.3390/bioengineering10030355.
Entz L, Falgayrac G, Chauveau C, Pasquier G, Lucas S Bone Rep. 2022; 17:101622.
PMID: 36187598 PMC: 9519944. DOI: 10.1016/j.bonr.2022.101622.
Carvalho M, Alves L, Bogalho I, Cabral J, da Silva C Front Cell Dev Biol. 2021; 9:747521.
PMID: 34676216 PMC: 8523799. DOI: 10.3389/fcell.2021.747521.
Capella-Monsonis H, De Pieri A, Peixoto R, Korntner S, Zeugolis D Stem Cell Res Ther. 2020; 11(1):510.
PMID: 33246508 PMC: 7694925. DOI: 10.1186/s13287-020-02021-x.
Soluble matrix protein is a potent modulator of mesenchymal stem cell performance.
Yeo G, Weiss A Proc Natl Acad Sci U S A. 2019; 116(6):2042-2051.
PMID: 30659152 PMC: 6369744. DOI: 10.1073/pnas.1812951116.